James Perkins to Risk Assessment
This is a "connection" page, showing publications James Perkins has written about Risk Assessment.
Connection Strength
0.689
-
Are we underestimating the quality of aviremic hepatitis C-positive kidneys? Time to reconsider. Am J Transplant. 2018 10; 18(10):2465-2472.
Score: 0.362
-
The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl. 2010 Jul; 16(7):874-84.
Score: 0.053
-
Metabolic syndrome: a new view of some familiar transplant risks. Liver Transpl. 2006 Mar; 12(3):485-6.
Score: 0.039
-
Increasing the liver donor pool through donation after cardiac death. Liver Transpl. 2006 Mar; 12(3):487-8.
Score: 0.039
-
Predicting posttransplantation infection risk with gene polymorphisms. Liver Transpl. 2006 Mar; 12(3):488-9.
Score: 0.039
-
Indications for chronic albumin infusion. Liver Transpl. 2006 Feb; 12(2):320-1.
Score: 0.039
-
Percutaneous transhepatic balloon dilation for portal venous stenosis. Liver Transpl. 2006 Feb; 12(2):321-2.
Score: 0.039
-
The impact of public health service increased risk donors in pediatric liver transplantation. Pediatr Transplant. 2020 06; 24(4):e13712.
Score: 0.026
-
Listing practices and graft utilization of hepatitis C-positive deceased donors in liver and kidney transplant. Surgery. 2019 07; 166(1):102-108.
Score: 0.025
-
Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation. Hepatology. 2012 Jul; 56(1):28-38.
Score: 0.015
-
Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl. 2008 May; 14(5):604-10.
Score: 0.011